Congress:
EuroSafe Imaging 2019
Keywords:
Action 11 - Dialogue with industry, Action 3 - Image quality assessment based on clinical indications, Action 13 - Stakeholder engagement and collaboration, Radioprotection / Radiation dose, Nuclear medicine, CT, Nuclear medicine conventional, Equipment, Technical aspects, Safety, Occupational / Environmental hazards, Radiotherapy techniques, Quality assurance
Authors:
B. C. Godthelp, K. Van Slambrouck
DOI:
10.26044/esi2019/ESI-0096
Conclusion and recommendations
Since 2010,
the WGMA has organized more than 5 multi stakeholder workshops,
2 inspector workshops,
1 common action week on inspection of justification in radiology,
and has published 10 position papers .
The WGMA provides through these position papers tools to assist the proper transposition and implementation of these EU Directive-requirements.
This included the individual justification as well as justification of new types or classes of practices and the accidental and unintended exposures.
All HERCA papers are freely available on the HERCA website: www.herca.org.
Over the last years “transposition” of the EU-directive was the most important issue for the HERCA Member States.
In the next years “implementation” of the EU-directive will be the most important issue.
In the coming years (2019-2021),
the WGMA will assess the major changes which have occurred since the Directive transposition and the possible difficulties on selected topics such as generic justification,
questions related to medical equipment (especially Art 78 of the BSS Directive),
and clinical audits.
HERCA WGMA will continue to be a platform for the member states for sharing information on these topics among radiation protection authorities but also with the professional societies and the manufacturers.